105 results
Page 5 of 6
8-K
EX-99.1
7101jobxqx2a55og
17 Apr 18
EyeGate Announces Completion of $11.25 Million Public Offering
12:00am
8-K
ijivgf xiynm1
13 Apr 18
EyeGate Announces $11.25 Million Public Offering
12:00am
8-K
EX-99.1
0awkhsm
13 Apr 18
EyeGate Announces $11.25 Million Public Offering
12:00am
8-K
EX-10.1
afmhq6hrqam
10 Jul 15
EyeGate Signs Licensing Agreement with Valeant Pharmaceuticals for EGP-437 Combination Product in Uveitis
12:00am
10-K
eqoe9vd7dr8j
31 Mar 15
Annual report
12:00am
424B4
8ipuaghy
13 Feb 15
Prospectus supplement with pricing info
12:00am